A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity
MOLECULAR PHARMACEUTICS(2018)
Abstract
Flurbiprofen, a hydrophobic COX inhibitor, was coordinated axially with oxoplatin to form a new conjugate, cis,cis,trans-[Pt(IV)(NH3)(2)Cl-2(flurbiprofen)(2)]. The successful synthesis of this new conjugate was confirmed by H-1, C-13, and Pt-195 NMR. The potential of this conjugate being reduced to cisplatin and subsequently exerting its DNA cross-linking ability was verified using cyclic voltammetry (CV), HPLC, and mass spectrometry (MS). This conjugate showed markedly higher cytotoxicity on many cancer cell lines than cisplatin, flurbiprofen, and their physical mixture (mole ratio, cisplatin:flurbiprofen = 1:2). This is consistent with the result of an apoptosisinducing assay. This conjugate spontaneously assembles carrier-free nanopartides in aqueous solution, which is confirmed by DLS, TEM, SEM, and AFM, and thus facilitates cellular uptake and markedly improves its cytotoxicity and apoptosis-inducing ability in vitro.
MoreTranslated text
Key words
cisplatin,nanostructure,carrier-free,cyclooxygenase inhibitor,cellular uptake
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined